β2m−/− mice, which lack CD8+ and NKT cells, fed with CD-HFD showed no liver damage, fibrosis and NASH and lower levels of cholesterol and triglyceride compared to CD-HFD-fed WT mice. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.